ANTIDIABETIC AGENTS - MISCELLANEOUS

Similar documents
ANTIDIABETIC AGENTS - MISCELLANEOUS

ANTIDIABETIC AGENTS - MISCELLANEOUS

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

Step Therapy Requirements

Step Therapy Requirements. Effective: 05/01/2018

ANTICONVULSANTS. Details

Step Therapy Requirements. Effective: 1/1/2019

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

Step Therapy Requirements. Effective: 11/01/2018

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

FirstCarolinaCare Insurance Company. Step Therapy Requirements

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

Step Therapy Requirements. Effective: 12/01/2016

Step Therapy Requirements. Effective: 03/01/2015

FirstCarolinaCare Insurance Company Step Therapy Requirements

2017 Step Therapy Criteria

ALLERGIC CONJUNCTIVITIS AGENTS

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

2018 Step Therapy Criteria

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

WELLCARE/ OHANA HEALTH PLAN 2015 STEP THERAPY CRITERIA (No Changes Made Since: 08/2015)

ALPHA GLUCOSIDASE INHIBITOR THERAPY

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

2019 STEP THERAPY CRITERIA UCare Individual & Family Plans UCare Individual & Family Plans with Fairview

ACYCLOVIR OINT (CCHP2017)

2017 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

Step Therapy Medications

ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR

Simply Step Therapy Document September 2018 Y0114_18_33074_I_009

2018 PDP Premier Step Therapy Document September 2018 Y0114_18_33144_I_009

Step Therapy Criteria 2019

Step Therapy Group. Atypical Antipsychotic Agents

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO) and Stride SM Value Rx Plus (HMO) Step Therapy Requirements

2019 PDP Basic Step Therapy Document

ANTICONVULSANT STEP THERAPY

ATYPICAL ANTIPSYCHOTICS

**CRITERIA UNDER CMS REVIEW**

CARE N CARE HEALTH PLAN

ACYCLOVIR OINT (CCHP2017)

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO), Stride SM Value Rx Plus (HMO) and Stride SM Gain Rx (HMO)

SelectHealth Advantage 2018 Step Therapy Criteria. Previous trial on at least ONE: Generic topical acne treatment. Previous trial on: alendronate

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Health Choice Generations 1 Tier Gold Effective Date: 11/01/2018.

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Optima Tier Gold Formulary Date Effective: November 1, 2018.

ACYCLOVIR OINT (CCHP2017)

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria

SelectHealth Advantage 2018 Step Therapy Criteria Previous trial on at least ONE: Generic topical acne treatment

ALBUTEROL - SCORE{XE "ALBUTEROL - SCORE"}

ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019

2017 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

ADHD STIMULANTS-S(SHC)

Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18

ACYCLOVIR OINT (CCHP2017)

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Farm Bureau Health Plans Date Effective: November 1, 2018.

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018

2018 STEP THERAPY CRITERIA UCare Connect (SNBC) MinnesotaCare Prepaid Medical Assistance Program (PMAP) Minnesota Senior Care Plus (MSC+)

2015 Step Therapy Prior Authorization Medical Necessity Guidelines

SelectHealth Advantage 2019 Step Therapy Criteria Previous trial on at least ONE: Generic topical acne treatment

ANTICONVULSANT THERAPY

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Golden State Medicare Health Plan, Golden (HMO) Last Updated: 09/01/2018

Step Therapy Group Algorithm Steps

ANGIOTENSIN RECEPTOR BLOCKERS

Mercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria

Y0133_StepTherapyCriteria _C 10/18/18 Y0133_StepTherapyCriteria _C es 10/18/18

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

ADHD STIMULANTS - SCORE

2019 Simply Step Therapy Document

ALZHEIMER'S DRUGS. Details. Step 2: Exelon Patch 13.3 mg/24 hour transdermal Exelon Patch 4.6 mg/24 hr transdermal

Step Therapy Criteria

DPP4 INHIBITORS. Products Affected Step 2: Janumet 50 mg-1,000 mg tablet Janumet 50 mg-500 mg tablet Januvia 100 mg tablet Januvia 25 mg tablet

Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria

ADHD STIMULANTS - SCORE

Transcription:

ANTIDIABETIC AGENTS - MISCELLANEOUS Glyxambi 10 mg-5 mg tablet Glyxambi 25 mg-5 mg tablet Invokamet 150 mg-1,000 mg tablet Invokamet 150 mg-500 mg tablet Invokamet 50 mg-1,000 mg tablet Invokamet 50 mg-500 mg tablet Invokamet XR 150 mg-1,000 mg tablet, extended release Invokamet XR 150 mg-500 mg tablet, extended release Invokamet XR 50 mg-1,000 mg tablet, extended release Invokamet XR 50 mg-500 mg tablet, extended release Invokana 100 mg tablet Invokana 300 mg tablet Jardiance 10 mg tablet Jardiance 25 mg tablet Synjardy 12.5 mg-1,000 mg tablet Synjardy 12.5 mg-500 mg tablet Synjardy 5 mg-1,000 mg tablet Synjardy 5 mg-500 mg tablet Synjardy XR 10 mg-1,000 mg tablet, extended release Synjardy XR 12.5 mg-1,000 mg tablet, extended release Synjardy XR 25 mg-1,000 mg tablet, extended release Synjardy XR 5 mg-1,000 mg tablet, extended release PRIOR CLAIM FOR METFORMIN, METFORMIN ER, A SULFONYLUREA AGENT (GLYBURIDE, GLIPIZIDE, GLIMEPIRIDE, TOLAZAMIDE, TOLBUTAMIDE), COMBINATION OF A SULFONYLUREA-METFORMIN, PIOGLITAZONE, OR A COMBINATION PIOGLITAZONE-METFORMIN OR PIOGLITAZONE- GLIMEPIRIDE WITHIN THE PAST 120 DAYS. H2986_PD_049 1

ANTI-INFLAMMATORY AGENTS - GI Dipentum 250 mg capsule PRIOR CLAIM FOR ANY 1 OF THE FOLLOWING: BALSALAZIDE, APRISO, DELZICOL, LIALDA, OR MESALAMINE DR 800 MG TAB WITHIN THE PAST 120 DAYS. 2

ANTIPSYCHOTIC AGENTS clozapine 100 mg disintegrating tablet clozapine 12.5 mg disintegrating tablet clozapine 150 mg disintegrating tablet clozapine 200 mg disintegrating tablet clozapine 25 mg disintegrating tablet Fanapt 1 mg tablet Fanapt 10 mg tablet Fanapt 12 mg tablet Fanapt 1mg(2)-2 mg(2)-4mg(2)-6 mg(2) tablets in a dose pack Fanapt 2 mg tablet Fanapt 4 mg tablet Fanapt 6 mg tablet Fanapt 8 mg tablet Saphris (black cherry) 10 mg sublingual tablet Saphris (black cherry) 2.5 mg sublingual tablet Saphris (black cherry) 5 mg sublingual tablet Versacloz 50 mg/ml oral suspension Vraylar 1.5 mg (1)-3 mg (6) capsules in a dose pack Vraylar 1.5 mg capsule Vraylar 3 mg capsule Vraylar 4.5 mg capsule Vraylar 6 mg capsule PRIOR CLAIM FOR FORMULARY VERSIONS OF ANY TWO ANTIPSYCHOTICS: RISPERIDONE TABLET, RISPERIDONE DISINTEGRATING TABLET, CLOZAPINE TABLET, OLANZAPINE TABLET, OLANZAPINE ORAL DISINTEGRATING TABLET, IMMEDIATE RELEASE QUETIAPINE FUMARATE, ZIPRASIDONE, ARIPIPRAZOLE TABS/ODT WITHIN THE PAST 365 DAYS H2986_PD_049 3

ANTIPSYCHOTIC AGENTS II Rexulti 0.25 mg tablet Rexulti 0.5 mg tablet Rexulti 1 mg tablet Rexulti 2 mg tablet Rexulti 3 mg tablet Rexulti 4 mg tablet PRIOR CLAIM FOR TWO (2) FORMULARY VERSIONS OF ATYPICAL ANTIPSYCHOTICS (RISPERIDONE, CLOZAPINE, OLANZAPINE, QUETIAPINE FUMARATE, ARIPIPRAZOLE OR ZIPRASIDONE) OR A SSRI (CITALOPRAM, FLUOXETINE, PAROXETINE, SERTRALINE) OR SNRI (VENLAFAXINE OR DULOXETINE) WITHIN THE PAST 365 DAYS 4

ANTIULCER AGENTS Dexilant 30 mg capsule, delayed release Dexilant 60 mg capsule, delayed release PRIOR CLAIM FOR GENERIC FEDERAL LEGEND OMEPRAZOLE, PANTOPRAZOLE, OR LANSOPRAZOLE WITHIN THE PAST 120 DAYS. H2986_PD_049 5

B VERSUS D ADMINISTRATIVE STEP cyclophosphamide 25 mg capsule cyclophosphamide 50 mg capsule methotrexate sodium 2.5 mg tablet Trexall 10 mg tablet Trexall 15 mg tablet Trexall 5 mg tablet Trexall 7.5 mg tablet Xatmep 2.5 mg/ml oral solution IN ORDER TO ASSIST IN A PART B VS. D PAYMENT DETERMINATION, A PRIOR CLAIM SEEN FOR A RHEUMATOID ARTHRITIS, PSORIASIS OR ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS DRUG WITHIN THE PAST 120 DAYS WILL QUALIFY FOR PART D PAYMENT. ALL OTHER INDICATIONS WILL HAVE A PART B VS. D PAYMENT DETERMINATION MADE THROUGH THE FORMULARY EXCEPTION PROCESS PRIOR TO THE APPROVAL OF THE DRUG. 6

ELUXADOLINE Viberzi 100 mg tablet Viberzi 75 mg tablet PRIOR CLAIM FOR DICYCLOMINE AND XIFAXAN 550MG WITHIN THE PAST 120 DAYS. H2986_PD_049 7

GABAPENTIN SR Gralise 300 mg tablet,extended release Gralise 30-Day Starter Pack 300 mg (9)- 600 mg (69) tablet,ext. release Gralise 600 mg tablet,extended release PRIOR CLAIM FOR GABAPENTIN IMMEDIATE RELEASE WITHIN THE PAST 120 DAYS. 8

LESINURAD Zurampic 200 mg tablet PRIOR CLAIM FOR ULORIC OR ALLOPURINOL TABLETS WITHIN THE PAST 120 DAYS. H2986_PD_049 9

LISINOPRIL ORAL SOLUTION Qbrelis 1 mg/ml oral solution PRIOR CLAIM FOR GENERIC LISINOPRIL WITHIN THE PAST 120 DAYS. 10

METFORMIN ER metformin ER 1,000 mg tablet,extended release 24hr metformin ER 500 mg tablet,extended release 24hr PRIOR CLAIM FOR METFORMIN HCL ER TAB ER 24H (GENERIC GLUCOPHAGE XR) WITHIN THE PAST 120 DAYS. H2986_PD_049 11

NOVEL ORAL ANTICOAGULANTS Pradaxa 110 mg capsule Pradaxa 150 mg capsule Pradaxa 75 mg capsule PRIOR CLAIM FOR ELIQUIS AND XARELTO IN THE PAST 365 DAYS. 12

OPHTHALMIC ANTIHISTAMINES - NO OTC Alrex 0.2 % eye drops,suspension Bepreve 1.5 % eye drops PRIOR CLAIM FOR LEVOCETIRIZINE, CROMOLYN SODIUM, EPINASTINE, OR OLOPATADINE 0.1% EYE DROPS WITHIN THE PAST 120 DAYS H2986_PD_049 13

QUETIAPINE FUMARATE EXTENDED RELEASE quetiapine ER 150 mg tablet,extended release 24 hr quetiapine ER 200 mg tablet,extended release 24 hr quetiapine ER 300 mg tablet,extended release 24 hr quetiapine ER 400 mg tablet,extended release 24 hr quetiapine ER 50 mg tablet,extended release 24 hr PRIOR CLAIM FOR A FORMULARY VERSION OF ONE OF THE FOLLOWING: RISPERIDONE TABLET, RISPERIDONE DISINTEGRATING TABLET, CLOZAPINE TABLET, OLANZAPINE TABLET, OLANZAPINE ORAL DISINTEGRATING TABLET, IMMEDIATE RELEASE QUETIAPINE FUMARATE, ZIPRASIDONE,CITALOPRAM, FLUOXETINE, PAROXETINE, SERTRALINE, DULOXETINE, VENLAFAXINE, OR ARIPIPRAZOLE WITHIN THE PAST 365 DAYS. 14

RENIN ANGIOTENSIN SYSTEM INHIBITORS Edarbi 40 mg tablet Edarbi 80 mg tablet Edarbyclor 40 mg-12.5 mg tablet Edarbyclor 40 mg-25 mg tablet Tekamlo 150 mg-10 mg tablet Tekamlo 150 mg-5 mg tablet Tekamlo 300 mg-10 mg tablet Tekamlo 300 mg-5 mg tablet Tekturna 150 mg tablet Tekturna 300 mg tablet Tekturna HCT 150 mg-12.5 mg tablet Tekturna HCT 150 mg-25 mg tablet Tekturna HCT 300 mg-12.5 mg tablet Tekturna HCT 300 mg-25 mg tablet PRIOR CLAIM FOR AN ANGIOTENSIN CONVERTING ENZYME INHIBITOR (ACE INHIBITOR), OR ACE INHIBITOR COMBINATION OR A GENERIC ANGIOTENSIN RECEPTOR BLOCKER (ARB), OR GENERIC ARB COMBINATION WITHIN THE PAST 120 DAYS. H2986_PD_049 15

SPRITAM Spritam 1,000 mg tablet for oral suspension Spritam 250 mg tablet for oral suspension Spritam 500 mg tablet for oral suspension Spritam 750 mg tablet for oral suspension PRIOR CLAIM FOR LEVETIRACETAM SOLUTION IN THE PAST 120 DAYS 16

ZARXIO Zarxio 300 mcg/0.5 ml injection syringe Zarxio 480 mcg/0.8 ml injection syringe MUST HAVE PREVIOUSLY TRIED NEUPOGEN PRIOR TO ZARXIO H2986_PD_049 17

INDEX A Alrex 0.2 % eye drops,suspension... 13 B Bepreve 1.5 % eye drops... 13 C clozapine 100 mg disintegrating tablet... 3 clozapine 12.5 mg disintegrating tablet... 3 clozapine 150 mg disintegrating tablet... 3 clozapine 200 mg disintegrating tablet... 3 clozapine 25 mg disintegrating tablet... 3 cyclophosphamide 25 mg capsule... 6 cyclophosphamide 50 mg capsule... 6 D Dexilant 30 mg capsule, delayed release... 5 Dexilant 60 mg capsule, delayed release... 5 Dipentum 250 mg capsule... 2 E Edarbi 40 mg tablet... 15 Edarbi 80 mg tablet... 15 Edarbyclor 40 mg-12.5 mg tablet... 15 Edarbyclor 40 mg-25 mg tablet... 15 F Fanapt 1 mg tablet... 3 Fanapt 10 mg tablet... 3 Fanapt 12 mg tablet... 3 Fanapt 1mg(2)-2 mg(2)-4mg(2)-6 mg(2) tablets in a dose pack... 3 Fanapt 2 mg tablet... 3 Fanapt 4 mg tablet... 3 Fanapt 6 mg tablet... 3 Fanapt 8 mg tablet... 3 G Glyxambi 10 mg-5 mg tablet... 1 Glyxambi 25 mg-5 mg tablet... 1 Gralise 300 mg tablet,extended release... 8 Gralise 30-Day Starter Pack 300 mg (9)-600 mg (69) tablet,ext. release... 8 Gralise 600 mg tablet,extended release... 8 I Invokamet 150 mg-1,000 mg tablet... 1 Invokamet 150 mg-500 mg tablet... 1 Invokamet 50 mg-1,000 mg tablet... 1 Invokamet 50 mg-500 mg tablet... 1 Invokamet XR 150 mg-1,000 mg tablet, extended release... 1 Invokamet XR 150 mg-500 mg tablet, extended release... 1 Invokamet XR 50 mg-1,000 mg tablet, extended release... 1 Invokamet XR 50 mg-500 mg tablet, extended release... 1 Invokana 100 mg tablet... 1 Invokana 300 mg tablet... 1 J Jardiance 10 mg tablet... 1 Jardiance 25 mg tablet... 1 M metformin ER 1,000 mg tablet,extended release 24hr... 11 metformin ER 500 mg tablet,extended release 24hr... 11 methotrexate sodium 2.5 mg tablet... 6 P Pradaxa 110 mg capsule... 12 Pradaxa 150 mg capsule... 12 Pradaxa 75 mg capsule... 12 Q Qbrelis 1 mg/ml oral solution... 10 quetiapine ER 150 mg tablet,extended release 24 hr... 14 quetiapine ER 200 mg tablet,extended release 24 hr... 14 quetiapine ER 300 mg tablet,extended release 24 hr... 14 quetiapine ER 400 mg tablet,extended release 24 hr... 14 quetiapine ER 50 mg tablet,extended release 24 hr... 14 R Rexulti 0.25 mg tablet... 4 Rexulti 0.5 mg tablet... 4 Rexulti 1 mg tablet... 4 Rexulti 2 mg tablet... 4 Rexulti 3 mg tablet... 4 Rexulti 4 mg tablet... 4 18

S Saphris (black cherry) 10 mg sublingual tablet... 3 Saphris (black cherry) 2.5 mg sublingual tablet... 3 Saphris (black cherry) 5 mg sublingual tablet... 3 Spritam 1,000 mg tablet for oral suspension... 16 Spritam 250 mg tablet for oral suspension 16 Spritam 500 mg tablet for oral suspension 16 Spritam 750 mg tablet for oral suspension 16 Synjardy 12.5 mg-1,000 mg tablet... 1 Synjardy 12.5 mg-500 mg tablet... 1 Synjardy 5 mg-1,000 mg tablet... 1 Synjardy 5 mg-500 mg tablet... 1 Synjardy XR 10 mg-1,000 mg tablet, extended release... 1 Synjardy XR 12.5 mg-1,000 mg tablet, extended release... 1 Synjardy XR 25 mg-1,000 mg tablet, extended release... 1 Synjardy XR 5 mg-1,000 mg tablet, extended release... 1 T Tekamlo 150 mg-10 mg tablet... 15 Tekamlo 150 mg-5 mg tablet... 15 Tekamlo 300 mg-10 mg tablet... 15 Tekamlo 300 mg-5 mg tablet... 15 Tekturna 150 mg tablet... 15 Tekturna 300 mg tablet... 15 Tekturna HCT 150 mg-12.5 mg tablet... 15 Tekturna HCT 150 mg-25 mg tablet... 15 Tekturna HCT 300 mg-12.5 mg tablet... 15 Tekturna HCT 300 mg-25 mg tablet... 15 Trexall 10 mg tablet... 6 Trexall 15 mg tablet... 6 Trexall 5 mg tablet... 6 Trexall 7.5 mg tablet... 6 V Versacloz 50 mg/ml oral suspension... 3 Viberzi 100 mg tablet... 7 Viberzi 75 mg tablet... 7 Vraylar 1.5 mg (1)-3 mg (6) capsules in a dose pack... 3 Vraylar 1.5 mg capsule... 3 Vraylar 3 mg capsule... 3 Vraylar 4.5 mg capsule... 3 Vraylar 6 mg capsule... 3 X Xatmep 2.5 mg/ml oral solution... 6 Z Zarxio 300 mcg/0.5 ml injection syringe. 17 Zarxio 480 mcg/0.8 ml injection syringe. 17 Zurampic 200 mg tablet... 9 19